Literature DB >> 18790822

PET imaging of brain 5-HT1A receptors in the preoperative evaluation of temporal lobe epilepsy.

Adrien Didelot1, Philippe Ryvlin, Amélie Lothe, Isabelle Merlet, Alexander Hammers, François Mauguière.   

Abstract

[(18)F]MPPF PET has previously been used to identify the epileptic lobe in temporal lobe epilepsy (TLE) patients at the group level. This study aims to validate the visual analysis of [(18)F]MPPF PET in the assessment of individual TLE patients for their suitability to undergo temporal lobe resection. Forty-two patients suffering from TLE and 18 control subjects matched for age and gender were prospectively enrolled for [(18)F]MPPF PET. Four subtypes were defined according to the presurgical evaluation: mesio-TLE (MTLE, 32 patients), temporal neocortical epilepsy (NC, five patients), temporo-perisylvian epilepsy (T+, three patients) and temporal epilepsy without further information (t, two patients). Parametric binding potential (BP(ND)) images were obtained using a simplified reference tissue model. Three examiners, who were blinded to other data, visually interpreted each scan and delineated areas of decreased [(18)F]MPPF BP(ND). Statistical parametric mapping (SPM) analysis of MPPF BP(ND) images was also performed. Visual analysis showed a low rate of disagreement between the three examiners (7%). PET scans were considered normal in four patients (9.5%). In the remaining 38 patients (90.5%), areas of focal BP(ND) decrease were identified. A specific pattern was encountered in the MTLE subgroup, consisting of a BP(ND) decrease involving hippocampus, amygdala and temporal pole altogether. Combining the results from the presurgical investigations and the surgical outcome, we estimated that the area of BP(ND) decrease coincided with the epileptogenic zone in 40% of patients in the MTLE subgroup and 33% in the other TLE subtypes. This relatively low precision was due to 47% of patients who showed BP(ND) decreases in the insula ipsilateral to the epileptogenic lobe. The SPM analysis had much lower sensitivity (67%) to detect BP(ND) decreases in the epileptogenic temporal lobe, but revealed areas of increased BP(ND) outside the epileptogenic zone and bitemporal BP(ND) decreases of undetermined clinical significance, which were undetectable by visual analysis, in 29% of patients. In conclusion, visual analysis of [(18)F]MPPF BP(ND) images helps in the correct identification of the epileptogenic temporal lobe in all patients showing BP(ND) decreases, with a false negative rate inferior to 10% and no false positives in control subjects. All TLE patients with [(18)F]MPPF BP(ND) decreases involving hippocampus, amygdala and temporal pole together, with or without extension to the ipsilateral insula, were good candidates for anterior temporal lobectomy. All these patients became seizure free after surgery, even when the clinical presentation was not that of a typical MTLE, or when MRI failed to detect hippocampal atrophy.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18790822     DOI: 10.1093/brain/awn220

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  13 in total

1.  Serotonin 1A receptors, depression, and memory in temporal lobe epilepsy.

Authors:  William H Theodore; Edythe A Wiggs; Ashley R Martinez; Irene H Dustin; Omar I Khan; Shmuel Appel; Pat Reeves-Tyer; Susumu Sato
Journal:  Epilepsia       Date:  2011-11-02       Impact factor: 5.864

2.  (S)-5-(2'-Fluorophenyl)-N,N-dimethyl-1,2,3,4-tetrahydronaphthalen-2-amine, a Serotonin Receptor Modulator, Possesses Anticonvulsant, Prosocial, and Anxiolytic-like Properties in an Fmr1 Knockout Mouse Model of Fragile X Syndrome and Autism Spectrum Disorder.

Authors:  Jessica L Armstrong; Austen B Casey; Tanishka S Saraf; Munmun Mukherjee; Raymond G Booth; Clinton E Canal
Journal:  ACS Pharmacol Transl Sci       Date:  2020-02-21

3.  An assessment of MEG coherence imaging in the study of temporal lobe epilepsy.

Authors:  Kost Elisevich; Neetu Shukla; John E Moran; Brien Smith; Lonni Schultz; Karen Mason; Gregory L Barkley; Norman Tepley; Valentina Gumenyuk; Susan M Bowyer
Journal:  Epilepsia       Date:  2011-03-02       Impact factor: 5.864

4.  Quantitative multi-compartmental SPECT image analysis for lateralization of temporal lobe epilepsy.

Authors:  Kourosh Jafari-Khouzani; Kost Elisevich; Kastytis C Karvelis; Hamid Soltanian-Zadeh
Journal:  Epilepsy Res       Date:  2011-03-30       Impact factor: 3.045

5.  PET of serotonin 1A receptors and cerebral glucose metabolism for temporal lobectomy.

Authors:  William H Theodore; Ashley R Martinez; Omar I Khan; Clarissa J Liew; Sungyoung Auh; Irene M Dustin; John Heiss; Susumu Sato
Journal:  J Nucl Med       Date:  2012-07-10       Impact factor: 10.057

Review 6.  The role of different serotonin receptor subtypes in seizure susceptibility.

Authors:  Mohammad Hadi Gharedaghi; Mohammad Seyedabadi; Jean-Eric Ghia; Ahmad Reza Dehpour; Reza Rahimian
Journal:  Exp Brain Res       Date:  2013-11-14       Impact factor: 1.972

7.  Synthesis and in vivo evaluation of [(18)F]2-(4-(4-(2-(2-fluoroethoxy)phenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2H,4H)-dione ([(18)F]FECUMI-101) as an imaging probe for 5-HT1A receptor agonist in nonhuman primates.

Authors:  Vattoly J Majo; Matthew S Milak; Jaya Prabhakaran; Pratap Mali; Lyudmila Savenkova; Norman R Simpson; J John Mann; Ramin V Parsey; J S Dileep Kumar
Journal:  Bioorg Med Chem       Date:  2013-06-12       Impact factor: 3.641

8.  FLAIR signal and texture analysis for lateralizing mesial temporal lobe epilepsy.

Authors:  Kourosh Jafari-Khouzani; Kost Elisevich; Suresh Patel; Brien Smith; Hamid Soltanian-Zadeh
Journal:  Neuroimage       Date:  2009-09-08       Impact factor: 6.556

Review 9.  PET studies in epilepsy.

Authors:  Ismet Sarikaya
Journal:  Am J Nucl Med Mol Imaging       Date:  2015-10-12

10.  Classification and lateralization of temporal lobe epilepsies with and without hippocampal atrophy based on whole-brain automatic MRI segmentation.

Authors:  Shiva Keihaninejad; Rolf A Heckemann; Ioannis S Gousias; Joseph V Hajnal; John S Duncan; Paul Aljabar; Daniel Rueckert; Alexander Hammers
Journal:  PLoS One       Date:  2012-04-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.